SCHEMBL21992759

SCHEMBL21992759

CCc1cc(/C=C2\CCn3c2nc(=O)c2cc(Cl)ccc23)cc(OC)c1O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.55
▸ MEN1 O00255 5/20 0.50
▸ KMT2A Q03164 5/20 0.50
▸ POLB P06746 3/20 0.50
▸ TUBB4A P04350 6/20 0.48
▸ TUBB P07437 6/20 0.48
▸ TUBA3C P0DPH7 6/20 0.48
▸ TUBA1B P68363 6/20 0.48
▸ TUBA4A P68366 6/20 0.48
▸ TUBB4B P68371 6/20 0.48
▸ TUBB3 Q13509 6/20 0.48
▸ TUBB2A Q13885 6/20 0.48
▸ TUBB8 Q3ZCM7 6/20 0.48
▸ TUBA3E Q6PEY2 6/20 0.48
▸ TUBA1A Q71U36 6/20 0.48
▸ TUBA1C Q9BQE3 6/20 0.48
▸ TUBB6 Q9BUF5 6/20 0.48
▸ TUBB2B Q9BVA1 6/20 0.48
▸ TUBB1 Q9H4B7 6/20 0.48
▸ RAB9A P51151 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20704814 0.93 ALOX5 (0.63) ALOX5MEN1KMT2APOLBTUBB4A
SCHEMBL21931930 0.81 ALOX5 (0.63) ALOX5MEN1KMT2APOLBTUBB4A
SCHEMBL30859439 0.81 TUBB4A (0.67) ALOX5MEN1KMT2APOLBTUBB4A
SCHEMBL28380900 0.81 TUBB4A (0.67) ALOX5MEN1KMT2APOLBTUBB4A
SCHEMBL21931882 0.81 TUBB4A (0.67) ALOX5MEN1KMT2APOLBTUBB4A
SCHEMBL21992770 0.75 SMARCA4 (0.60) ALOX5MEN1KMT2ATUBB4ATUBB
SCHEMBL13977272 0.74 RAB9A (0.60) ALOX5MEN1KMT2APOLBTUBB4A
SCHEMBL11112931 0.72 ALOX5 (0.65) ALOX5MEN1KMT2APOLBTUBB4A
SCHEMBL11112929 0.72 ALOX5 (0.65) ALOX5MEN1KMT2APOLBTUBB4A
SCHEMBL25053623 0.72 RAB9A (0.62) ALOX5MEN1KMT2APOLBTUBB4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11583530-B2 Compounds for the prevention and treatment of medical disorders and uses thereof GALECTIN SCIENCES, LLC (US) 2023-02-21 — — US disclosed
US-20200147088-A1 Compounds for the Prevention and Treatment of Medical Disorders and Uses Thereof GALECTIN SCIENCES, LLC 2020-05-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200147088-A1 Compounds for the Prevention and Treatment of Medical Disorders and Uses Thereof LGALS1, LGALS2, LGALS3 ALOX5 570/4885MEN1 523/4885KMT2A 4754/4885
US-11583530-B2 Compounds for the prevention and treatment of medical disorders and uses thereof LGALS1, LGALS2, LGALS3 ALOX5 570/4885MEN1 523/4885KMT2A 4754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback